<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="document-matrix.xsl" type="text/xsl"?>
<!--	Version 1.0		Initial version
		Version 2.0		Related Variations added, Module 1 elementName corrected to m1-za
		Version 2.1		Minor typo updates
		Version 2.2	    Removal of Critical Errors not relevant for submission types
		Version 2.3		Update according to Renewals Change COntrol Request form signed 11 December 2024
		Version 3.0     Update to align with additional Sumission Types for the major config update of March 2025 -->

<sub_type_vs_toc version="3.0">
	<section number="1" name="Module 1 Administrative and Prescribing Information" content="NV" header="yes" elementName="m1-za"/>
	<section number="1.0" name="Correspondence" content="NV" header="yes" elementName="m1-0-correspondence"/>
	<section number="1.0.1" name="Letter of Application" content="NV" elementName="m1-0-1-application-letter">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content="E"/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="E"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="E"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="E"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="E"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="E"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="E"/>														 
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="E"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="E"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="E"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="E"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="E"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="E"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="E"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="E"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="E"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="E"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="E"/>
	</section>
	<section number="1.0.2" name="Note to Evaluator" content="NV" elementName="m1-0-2-note-to-evaluator">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content="P"/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.0.3" name="Correspondence from SAHPRA" content="NV" elementName="m1-0-3-correspondence-from-authority">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content="P"/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.0.4" name="Response to SAHPRA Request" content="NV" elementName="m1-0-4-response-to-authority">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content="P"/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.0.5" name="Meeting Information" content="NV" elementName="m1-0-5-meeting-info">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content="P"/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2" name="Application" content="NV" header="yes" elementName="m1-2-application"/>
	<section number="1.2.1" name="Application Forms" content="NV" elementName="m1-2-1-application-form">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="E"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="E"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="E"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="E"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="E"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="E"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="E"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="E"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="E"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="E"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="E"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="E"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="E"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="P"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2.2" name="Annexes" content="NV" header="yes" elementName="m1-2-2-annexes"/>
	<section number="1.2.2.1" name="Proof of Payment" content="NV" elementName="m1-2-2-1-proof-of-payment">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content="P"/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2.2.2" name="Letter of Authorisation" content="NV" elementName="m1-2-2-2-letter-of-authorisation">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="W"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="W"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="W"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="W"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="E"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="W"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="W"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="W"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="W"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="W"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="W"/>
	</section>
	<section number="1.2.2.3" name="Dossier Product Batch Information" content="NV" elementName="m1-2-2-3-dossier-product-batch-information">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2.2.4" name="Electronic Copy Declaration" content="NV" elementName="m1-2-2-4-electronic-copy-declaration">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="E"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="P"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2.2.5" name="Curriculum Vitae of the Person Responsible for Pharmacovigilance" content="NV" elementName="m1-2-2-5-cv-pharmacovigilance">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="E"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2.2.6" name="API Change Control" content="NV" elementName="m1-2-2-6-api-change-control">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="XW"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="XW"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="XW"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="XW"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="XW"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="XW"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.2.2.7" name="EMA Certificate for a Vaccine Antigen Master File (VAMF)" content="NV" elementName="m1-2-2-7-vamf-certificate">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="XE"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="XE"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="XE"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="XE"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="XE"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="XE"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="XE"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.2.8" name="EMA Certificate for a Plasma Master File (PMF)" content="NV" elementName="m1-2-2-8-pmf-certificate">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="XE"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="XE"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="XE"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="XE"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="XE"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="XE"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="XE"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.2.9" name="Declaration of Sameness for Replicas and Clones" content="NV" elementName="m1-2-2-9-declaration-sameness">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II -Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.2.10" name="Letter of Permission from HCR for Replica" content="NV" elementName="m1-2-2-10-letter-permission-hcr">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="XE"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.2.A" name="Additional Annexes" content="NV" elementName="m1-2-2-a-additional-annexes">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.3" name="Change in Applicant" content="NV" header="yes" elementName="m1-2-3-change-in-applicant"/>
	<section number="1.2.3.1" name="Letter of Authorisation from Product Owner to New Registrant" content="NV" elementName="m1-2-3-1-loa-from-prod-owner">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="XE"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="XE"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="XE"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="XE"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="XE"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="XE"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="XE"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="XE"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="XE"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="XE"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="XE"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="XE"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.3.2" name="Written Confirmation of Hand-over of Dossier" content="NV" elementName="m1-2-3-2-confirmation-of-hand-over">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="XE"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="XE"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="XE"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="XE"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="XE"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="XE"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="XE"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="XE"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="XE"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="XE"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="XE"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="XE"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.4" name="Patent Declaration" content="NV" elementName="m1-2-4-patent-declaration">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="XE"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="XE"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="1.2.5" name="Checklists, Validation Templates" content="NV" elementName="m1-2-5-checklists-val-templates">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="E"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="E"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="E"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="E"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="E"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="E"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="E"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="E"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="E"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="E"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="E"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="E"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="E"/>
	</section>
	<section number="1.2.A" name="Additional Administrative Information" content="NV" elementName="m1-2-a-additional-admin-info">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3" name="South African Product Information" content="NV" header="yes" elementName="m1-3-za-labelling-packaging"/>
	<section number="1.3.1" name="South African Professional Information" content="NV" header="yes" elementName="m1-3-1-sapi"/>
	<section number="1.3.1.1" name="Professional Information (PI)" content="NV" header="yes" elementName="m1-3-1-1-pi"/>
	<section number="1.3.1.1.1" name="PI - Approved" content="NV" elementName="m1-3-1-1-1-pi-approved">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.1.1.2" name="PI - Clean" content="NV" elementName="m1-3-1-1-2-pi-clean">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XW"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XW"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XW"/>
		<subType code="sub-type-15" displayName="Clone" content="XW"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XW"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="W"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.1.1.3" name="PI - Annotated" content="NV" elementName="m1-3-1-1-3-pi-annotated">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="W"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.1.2" name="Standard References" content="NV" header="yes" elementName="m1-3-1-2-std-refs"/>
	<section number="1.3.1.2.1" name="Reference Product - Local" content="NV" elementName="m1-3-1-2-1-ref-prod-local">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.1.2.2" name="Other References" content="NV" elementName="m1-3-1-2-2-other-refs">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.2" name="Patient Information Leaflet (PIL)" content="NV" header="yes" elementName="m1-3-2-pil"/>
	<section number="1.3.2.1" name="PIL - Approved" content="NV" elementName="m1-3-2-1-pil-approved">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.2.2" name="PIL - Clean" content="NV" elementName="m1-3-2-2-pil-clean">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XW"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XW"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XW"/>
		<subType code="sub-type-15" displayName="Clone" content="XW"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XW"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="W"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.2.3" name="PIL - Annotated" content="NV" elementName="m1-3-2-3-pil-annotated">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="E"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="E"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="E"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="E"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="E"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="E"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="W"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.3" name="Labels" content="NV" header="yes" elementName="m1-3-3-labels"/>
	<section number="1.3.3.1" name="Labels - Approved" content="NV" elementName="m1-3-3-1-labels-approved">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.3.2" name="Labels - Clean" content="NV" elementName="m1-3-3-2-labels-clean">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XW"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XW"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XW"/>
		<subType code="sub-type-15" displayName="Clone" content="XW"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XW"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.3.3" name="Labels - Annotated" content="NV" elementName="m1-3-3-3-labels-annotated">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.4" name="Braille" content="NV" elementName="m1-3-4-braille">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.5" name="Foreign Prescribing and Patient Information" content="NV" elementName="m1-3-5-foreign-prescribing-pat-info">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="XE"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="XE"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="XE"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="XE"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="XE"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="XE"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="XE"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="XE"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.6" name="Artwork and Samples" content="NV" header="yes" elementName="m1-3-6-artwork-samples"/>
	<section number="1.3.6.1" name="Statement Confirming Submission of Samples" content="NV" elementName="m1-3-6-1-statement-of-samples">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.6.2" name="Artwork and Pictures of Samples" content="NV" elementName="m1-3-6-2-artwork-pics-of-samples">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.6.3" name="Batch Manufacturing Record of the Sample" content="NV" elementName="m1-3-6-3-batch-of-samples">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.3.6.4" name="CoA of the Sample" content="NV" elementName="m1-3-6-4-coa-samples">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.4" name="Information about the Experts" content="NV" header="yes" elementName="m1-4-expert-information"/>
	<section number="1.4.1" name="Quality" content="NV" elementName="m1-4-1-quality">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.4.2" name="Nonclinical" content="NV" elementName="m1-4-2-non-clinical">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.4.3" name="Clinical" content="NV" elementName="m1-4-3-clinical">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5" name="Specific Requirements for different Types of Applications" content="NV" header="yes" elementName="m1-5-specific-requirements"/>
	<section number="1.5.1" name="Literature Based Submissions" content="NV" elementName="m1-5-1-literature-based">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.2" name="Amendments/Variations" content="NV" header="yes" elementName="m1-5-2-amendment"/>
	<section number="1.5.2.1" name="Tabulated Schedule of Amendments" content="NV" elementName="m1-5-2-1-amendment-schedule">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension-New Application" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="E"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="E"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="E"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="E"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="E"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="E"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.2.2" name="Medicines Register Details" content="NV" header="yes" elementName="m1-5-2-2-medicine-register"/>
	<section number="1.5.2.2.1" name="Medicines Register Details" content="NV" elementName="m1-5-2-2-1-medicine-register">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.2.2.2" name="Registration Certificates" content="NV" elementName="m1-5-2-2-2-registration-certificates">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="W"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="P"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.2.3" name="Affidavit by Responsible Pharmacist" content="NV" elementName="m1-5-2-3-affidavit">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XW"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XW"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="E"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="P"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.3" name="Proprietary Name Applications and Changes" content="NV" elementName="m1-5-3-proprietary-name">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="W"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="E"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.4" name="Genetically Modified Organisms" content="NV" elementName="m1-5-4-gmo">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.6" name="Generic Applications (BTIF)" content="NV" header="yes" elementName="m1-5-6-btif"/>
	<section number="1.5.6.1" name="BTIF" content="NV" elementName="m1-5-6-1-btif">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="XE"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="XE"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.6.2" name="Biowaiver" content="NV" elementName="m1-5-6-2-biowaiver">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="XE"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.7" name="Abridged Applications (Abridged/Verified Review Document)" content="NV" elementName="m1-5-7-abridged-apps">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="XE"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.5.A" name="Additional Types of Applications Specific Requirements" content="NV" elementName="m1-5-a-additional-types-applications">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.6" name="Environmental Risk Assessment" content="NV" header="yes" elementName="m1-6-environ-risk-assessment"/>
	<section number="1.6.1" name="Non-GMO (Genetically Modified Organisms)" content="NV" elementName="m1-6-1-nongmo">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.6.2" name="GMO (Genetically Modified Organisms)" content="NV" elementName="m1-6-2-gmo">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7" name="Good Manufacturing Practice" content="NV" header="yes" elementName="m1-7-gmp"/>
	<section number="1.7.1" name="Date of Last Inspection of each Site" content="NV" elementName="m1-7-1-last-inspection">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="W"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="W"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="W"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="W"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.2" name="Inspection Reports or Equivalent Document" content="NV" elementName="m1-7-2-inspection-report-or-equivalent">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.3" name="Latest GMP Certificate or a Copy of the Appropriate Licence" content="NV" elementName="m1-7-3-gmp-certificate">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="W"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="W"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.4" name="Release" content="NV" header="yes" elementName="m1-7-4-release"/>
	<section number="1.7.4.1" name="API" content="NV" elementName="m1-7-4-1-api">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.4.2" name="IPIs" content="NV" elementName="m1-7-4-2-ipi">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.4.3" name="Finished Product Release Control (FPRC) Tests" content="NV" elementName="m1-7-4-3-fprc-tests">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.4.4" name="Finished Product Release Responsibility (FPRR) Criteria" content="NV" elementName="m1-7-4-4-fprr-criteria">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.5" name="Confirmation of Contract" content="NV" elementName="m1-7-5-contract-confirmation">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.7" name="SAPC Registration" content="NV" elementName="m1-7-7-sapc-reg">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="W"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="W"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="W"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="W"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="W"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.8" name="Registration with Registrar of Companies" content="NV" elementName="m1-7-8-comp-reg">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="W"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="W"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="W"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="W"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="W"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="W"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="W"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="W"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="W"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.9" name="Other Documents Relating to the Applicant/PHCR" content="NV" elementName="m1-7-9-docs-phcr">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.11" name="Manufacturing Permits" content="NV" elementName="m1-7-11-manufacturing-permit">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.12" name="Inspection Flow Diagram" content="NV" elementName="m1-7-12-inspection-flow-diagram">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="E"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="E"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="E"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="E"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="E"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="E"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="E"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.13" name="Organogram" content="NV" elementName="m1-7-13-organogram">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.14" name="PQR" content="NV" elementName="m1-7-14-pqr">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.7.A" name="Additional GMP Documents" content="NV" elementName="m1-7-a-additional-gmp-documents">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="P"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.8" name="Information Relating to Pharmacovigilance" content="NV" header="yes" elementName="m1-8-info-relating-pv"/>
	<section number="1.8.1" name="Pharmacovigilance Systems" content="NV" elementName="m1-8-1-pv-systems">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="W"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="W"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.8.2" name="Risk Management Plan" content="NV" elementName="m1-8-2-risk-management-plan">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.9" name="Individual Patient Data - Statement of Availability" content="NV" header="yes" elementName="m1-9-indiv-patient-data"/>
	<section number="1.9" name="Individual Patient Data - Statement of Availability" content="NV" elementName="m1-9-indiv-patient-data">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.10" name="Foreign Regulatory Status" content="NV" header="yes" elementName="m1-10-foreign-reg-status"/>
	<section number="1.10.1" name="Tabulated List of Foreign Regulatory Status" content="NV" elementName="m1-10-1-countries-same-appl">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.10.2" name="Registration Certificate or Marketing Authorisation" content="NV" elementName="m1-10-2-foreign-reg-certif-or-ma">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.10.4" name="Data Set Similarities" content="NV" header="yes" elementName="m1-10-4-data-set-similarities"/>
	<section number="1.10.4.1" name="Data Set Similarities" content="NV" elementName="m1-10-4-1-data-set-similarities">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.10.4.2" name="Declaration of Sameness" content="NV" elementName="m1-10-4-2-declaration-sameness">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.10.5" name="RRA Reports" content="NV" elementName="m1-10-5-rra-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.10.6" name="CPP (WHO certification scheme)" content="NV" elementName="m1-10-6-cpp">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.12" name="Paediatric Development Programme" content="NV" header="yes" elementName="m1-12-paediatric-dev-program"/>
	<section number="1.12" name="Paediatric Development Programme" content="NV" elementName="m1-12-paediatric-dev-program">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="1.A" name="Additional Data" content="NV" header="yes" elementName="m1-a-additional-data"/>
	<section number="1.A" name="Additional Data" content="NV" elementName="m1-a-additional-data">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="P"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="P"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="P"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="P"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="P"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="P"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="P"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2" name="Summaries and Overviews" content="NV" header="yes" elementName="m2-common-technical-document-summaries"/>
	<section number="2.2" name="Introduction" content="NV" elementName="m2-2-introduction">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.3" name="Quality Overall Summary" content="NV" elementName="m2-3-quality-overall-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.4" name="Nonclinical Overview" content="NV" elementName="m2-4-nonclinical-overview">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.5" name="Clinical Overview" content="NV" elementName="m2-5-clinical-overview">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6" name="Nonclinical Summaries" content="NV" header="yes" elementName="m2-6-nonclinical-written-and-tabulated-summaries"/>
	<section number="2.6.1" name="Introduction" content="NV" elementName="m2-6-1-introduction">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6.2" name="Pharmacology Written Summary" content="NV" elementName="m2-6-2-pharmacology-written-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6.3" name="Pharmacology Tabulated Summary" content="NV" elementName="m2-6-3-pharmacology-tabulated-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6.4" name="Pharmacokinetics Written Summary" content="NV" elementName="m2-6-4-pharmacokinetics-written-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6.5" name="Pharmacokinetics Tabulated Summary" content="NV" elementName="m2-6-5-pharmacokinetics-tabulated-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6.6" name="Toxicology Written Summary" content="NV" elementName="m2-6-6-toxicology-written-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.6.7" name="Toxicology Tabulated Summary" content="NV" elementName="m2-6-7-toxicology-tabulated-summary">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.7" name="Clinical Summaries" content="NV" header="yes" elementName="m2-7-clinical-summary"/>
	<section number="2.7.1" name="Summary of Biopharmaceutic Studies and Associated Analytical Methods" content="NV" elementName="m2-7-1-summary-of-biopharmaceutic-studies-and-associated-analytical-methods">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.7.2" name="Summary of Clinical Pharmacology Studies" content="NV" elementName="m2-7-2-summary-of-clinical-pharmacology-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.7.3" name="Summary of Clinical Efficacy" content="NV" elementName="m2-7-3-summary-of-clinical-efficacy">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.7.4" name="Summary of Clinical Safety" content="NV" elementName="m2-7-4-summary-of-clinical-safety">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.7.5" name="Literature References" content="NV" elementName="m2-7-5-literature-references">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="2.7.6" name="Synopsis of Individual Studies" content="NV" elementName="m2-7-6-synopses-of-individual-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3" name="Quality" content="NV" header="yes" elementName="m3-quality"/>
	<section number="3.2" name="Body of Data" content="NV" header="yes" elementName="m3-2-body-of-data"/>
	<section number="3.2.S" name="Drug Substance" content="NV" header="yes" elementName="m3-2-s-drug-substance"/>
	<section number="3.2.S.1" name="General Information" content="NV" header="yes" elementName="m3-2-s-1-general-information"/>
	<section number="3.2.S.1.1" name="Nomenclature" content="NV" elementName="m3-2-s-1-1-nomenclature">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.1.2" name="Structure" content="NV" elementName="m3-2-s-1-2-structure">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.1.3" name="General Properties" content="NV" elementName="m3-2-s-1-3-general-properties">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.2" name="Manufacturer" content="NV" header="yes" elementName="m3-2-s-2-manufacture"/>
	<section number="3.2.S.2.1" name="Manufacturer(s)" content="NV" elementName="m3-2-s-2-1-manufacturer">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.2.2" name="Description of Manufacturing Process and Process Controls" content="NV" elementName="m3-2-s-2-2-description-of-manufacturing-process-and-process-controls">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.2.3" name="Control of Materials" content="NV" elementName="m3-2-s-2-3-control-of-materials">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.2.4" name="Control of Critical Steps and Intermediates" content="NV" elementName="m3-2-s-2-4-controls-of-critical-steps-and-intermediates">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.2.5" name="Process Validation and/or Evaluation" content="NV" elementName="m3-2-s-2-5-process-validation-and-or-evaluation">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.2.6" name="Manufacturing Process Development" content="NV" elementName="m3-2-s-2-6-manufacturing-process-development">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.3" name="Characterisation" content="NV" header="yes" elementName="m3-2-s-3-characterisation"/>
	<section number="3.2.S.3.1" name="Elucidation of Structure and Other Characteristics" content="NV" elementName="m3-2-s-3-1-elucidation-of-structure-and-other-characteristics">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.3.2" name="Impurities" content="NV" elementName="m3-2-s-3-2-impurities">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.4" name="Control of Drug Substance" content="NV" header="yes" elementName="m3-2-s-4-control-of-drug-substance"/>
	<section number="3.2.S.4" name="Control Strategy" content="NV" elementName="m3-2-s-4-control-of-drug-substance">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="NV"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="NV"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="NV"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="NV"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="3.2.S.4.1" name="Specification" content="NV" elementName="m3-2-s-4-1-specification">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="W"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="W"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="W"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="W"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="W"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.4.2" name="Analytical Procedures" content="NV" elementName="m3-2-s-4-2-analytical-procedures">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.4.3" name="Validation of Analytical Procedures" content="NV" elementName="m3-2-s-4-3-validation-of-analytical-procedures">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.4.4" name="Batch Analyses" content="NV" elementName="m3-2-s-4-4-batch-analyses">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.4.5" name="Justification of Specification" content="NV" elementName="m3-2-s-4-5-justification-of-specification">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.5" name="Reference Standards or Materials" content="NV" elementName="m3-2-s-5-reference-standards-or-materials">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.6" name="Container Closure System" content="NV" elementName="m3-2-s-6-container-closure-system">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.7" name="Stability" content="NV" header="yes" elementName="m3-2-s-7-stability"/>
	<section number="3.2.S.7.1" name="Stability Summary and Conclusions" content="NV" elementName="m3-2-s-7-1-stability-summary-and-conclusions">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.7.2" name="Post-approval Stability Protocol and Stability Commitment" content="NV" elementName="m3-2-s-7-2-post-approval-stability-protocol-and-stability-commitment">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.S.7.3" name="Pharmaceutical Development" content="NV" elementName="m3-2-s-7-3-stability-data">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P" name="Drug Product" content="NV" header="yes" elementName="m3-2-p-drug-product"/>
	<section number="3.2.P.1" name="Description and Composition of the Drug Product" content="NV" elementName="m3-2-p-1-description-and-composition-of-the-drug-product">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.2" name="Pharmaceutical Development" content="NV" elementName="m3-2-p-2-pharmaceutical-development">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.3" name="Manufacture" content="NV" header="yes" elementName="m3-2-p-3-manufacture"/>
	<section number="3.2.P.3.1" name="Manufacture(s)" content="NV" elementName="m3-2-p-3-1-manufacturers">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.3.2" name="Batch Formula" content="NV" elementName="m3-2-p-3-2-batch-formula">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.3.3" name="Description of Manufacturing Process Controls" content="NV" elementName="m3-2-p-3-3-description-of-manufacturing-process-and-process-controls">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.3.4" name="Controls of Critical Steps and Intermediates" content="NV" elementName="m3-2-p-3-4-controls-of-critical-steps-and-intermediates">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.3.5" name="Process Validation and/or Evaluation" content="NV" elementName="m3-2-p-3-5-process-validation-and-or-evaluation">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.4" name="Control of Excipients" content="NV" header="yes" elementName="m3-2-p-4-control-of-excipients"/>
	<section number="3.2.P.4.1" name="Specifications" content="NV" elementName="m3-2-p-4-1-specifications">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.4.2" name="Analytical Procedures" content="NV" elementName="m3-2-p-4-2-analytical-procedures">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.4.3" name="Validation of Analytical Procedures" content="NV" elementName="m3-2-p-4-3-validation-of-analytical-procedures">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.4.4" name="Justification of Specifications" content="NV" elementName="m3-2-p-4-4-justification-of-specifications">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.4.5" name="Excipients of Human or Animal Origin" content="NV" elementName="m3-2-p-4-5-excipients-of-human-or-animal-origin">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.4.6" name="Novel Excipients" content="NV" elementName="m3-2-p-4-6-novel-excipients">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.5" name="Control of Drug Product" content="NV" header="yes" elementName="m3-2-p-5-control-of-drug-product"/>
	<section number="3.2.P.5" name="Control Strategy" content="NV" elementName="m3-2-p-5-control-of-drug-product">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="NV"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="NV"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="NV"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="NV"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="3.2.P.5.1" name="Specification" content="NV" elementName="m3-2-p-5-1-specifications">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.5.2" name="Analytical Procedures" content="NV" elementName="m3-2-p-5-2-analytical-procedures">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.5.3" name="Validation of Analytical Procedures" content="NV" elementName="m3-2-p-5-3-validation-of-analytical-procedures">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.5.4" name="Batch Analyses" content="NV" elementName="m3-2-p-5-4-batch-analyses">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.5.5" name="Characterisation of Impurities" content="NV" elementName="m3-2-p-5-5-characterisation-of-impurities">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.5.6" name="Justification of Specification" content="NV" elementName="m3-2-p-5-6-justification-of-specifications">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.6" name="Reference Standards or Materials" content="NV" elementName="m3-2-p-6-reference-standards-or-materials">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.7" name="Container Closure System" content="NV" elementName="m3-2-p-7-container-closure-system">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.8" name="Stability" content="NV" header="yes" elementName="m3-2-p-8-stability"/>
	<section number="3.2.P.8.1" name="Stability Summary and Conclusions" content="NV" elementName="m3-2-p-8-1-stability-summary-and-conclusion">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.8.2" name="Post-approval Stability Protocol and Stability" content="NV" elementName="m3-2-p-8-2-post-approval-stability-protocol-and-stability-commitment">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.P.8.3" name="Stability Data" content="NV" elementName="m3-2-p-8-3-stability-data">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.A" name="Appendices" content="NV" header="yes" elementName="m3-2-a-appendices"/>
	<section number="3.2.A.1" name="Facilities and Equipment" content="NV" elementName="m3-2-a-1-facilities-and-equipment">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="NV"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="NV"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="NV"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="NV"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="3.2.A.2" name="Adventitious Agents Safety Evaluation" content="NV" elementName="m3-2-a-2-adventitious-agents-safety-evaluation">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="NV"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="NV"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="NV"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="NV"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="3.2.A.3" name="Excipient" content="NV" elementName="m3-2-a-3-excipients">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="NV"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="NV"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="NV"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="NV"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="3.2.R" name="Regional Information" content="NV" header="yes" elementName="m3-2-r-regional-information"/>
	<section number="3.2.R.1" name="Pharmaceutical and Biological availability" content="NV" header="yes" elementName="node-extension-Pharmaceutical-and-Biological-availability"/>
	<section number="3.2.R.1.1" name="Overview" content="NV" elementName="node-extension-Overview">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.1.2" name="Reference product/s (local and foreign)" content="NV" elementName="node-extension-Reference-product/s-(local and foreign)">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.1.3" name="Certificates of Analysis" content="NV" elementName="node-extension-Certificates-of-Analysis">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.1.4" name="Pharmaceutical availability studies" content="NV" elementName="node-extension-Pharmaceutical-availability-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="P"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="P"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="P"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="P"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="P"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.2" name="Parent API Manufacturer with various sites" content="NV" elementName="node-extension-Parent-API-Manufacturer-with-various-sites">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.3" name="Certificates of suitability with respect to the Ph.Eur. (CEPs)" content="NV" elementName="node-extension-Certificates-of-suitability-with-respect-to-the-Ph.Eur">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.4" name="3.2.R.4 Multiple API manufacturers" content="NV" elementName="node-extension-3.2.R.4-Multiple-API-manufacturers">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.5" name="3.2.R.5 Medical device" content="NV" elementName="node-extension-3.2.R.5-Medical-device">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="NV"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.6" name="3.2.R.6 Materials of animal and-or human origin" content="NV" elementName="node-extension-3.2.R.6-Materials-of-animal-and-or-human-origin">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="P"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.7" name="3.2.R.7 Batch records of samples" content="NV" elementName="node-extension-3.2.R.7-Batch-records-of-samples">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="P"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="P"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="P"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="P"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="P"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.8" name="3.2.R.8 Other" content="NV" header="yes" elementName="node-extension-3.2.R.8 Other"/>
	<section number="3.2.R.8" name="SCORE" content="NV" elementName="node-extension-SCORE">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="XE"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="XE"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="XE"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="XE"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="XE"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="XE"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="XE"/>
		<subType code="sub-type-15" displayName="Clone" content="XE"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="XE"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="XE"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="XE"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="XE"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="XE"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.8" name="QOS" content="NV" elementName="node-extension-QOS">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="P"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.2.R.8" name="QIS" content="NV" elementName="node-extension-QIS">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="E"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="E"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="E"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="E"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="E"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="E"/>
		<subType code="sub-type-15" displayName="Clone" content="E"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="E"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="P"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="P"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="P"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="P"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="P"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="P"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="P"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="P"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="P"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="P"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="E"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="P"/>
	</section>
	<section number="3.3" name="Literature References" content="NV" header="yes" elementName="m3-3-literature-references"/>
	<section number="3.3" name="Literature References" content="NV" elementName="m3-3-literature-references">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="NV"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="NV"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="NV"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="NV"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="NV"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="NV"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="NV"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="NV"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4" name="Nonclinical Study Reports" content="NV" header="yes" elementName="m4-nonclinical-study-reports"/>
	<section number="4.2" name="Study Reports" content="NV" header="yes" elementName="m4-2-study-reports"/>
	<section number="4.2.1" name="Study Reports" content="NV" header="yes" elementName="m4-2-1-pharmacology"/>
	<section number="4.2.1.1" name="Primary Pharmacodynamics" content="NV" elementName="m4-2-1-1-primary-pharmacodynamics">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.1.2" name="Secondary Pharmacodynamics" content="NV" elementName="m4-2-1-2-secondary-pharmacodynamics">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.1.3" name="Safety Pharmacology" content="NV" elementName="m4-2-1-3-safety-pharmacology">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.1.4" name="Pharmacodynamic Drug Interactions" content="NV" elementName="m4-2-1-4-pharmacodynamic-drug-interactions">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2" name="Pharmacokinetics" content="NV" header="yes" elementName="m4-2-2-pharmacokinetics"/>
	<section number="4.2.2.1" name="Analytical Methods and Validation Reports" content="NV" elementName="m4-2-2-1-analytical-methods-and-validation-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2.2" name="Absorption" content="NV" elementName="m4-2-2-2-absorption">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2.3" name="Distribution" content="NV" elementName="m4-2-2-3-distribution">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2.4" name="Metabolism" content="NV" elementName="m4-2-2-4-metabolism">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2.5" name="Excretion" content="NV" elementName="m4-2-2-5-excretion">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2.6" name="Pharmacokinetic Drug Interactions" content="NV" elementName="m4-2-2-6-pharmacokinetic-drug-interactions">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.2.7" name="Other Pharmacokinetic Studies" content="NV" elementName="m4-2-2-7-other-pharmacokinetic-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3" name="Toxicology" content="NV" header="yes" elementName="m4-2-3-toxicology"/>
	<section number="4.2.3.1" name="Single Dose Toxicity" content="NV" elementName="m4-2-3-1-single-dose-toxicity">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.2" name="Repeat Dose Toxicity" content="NV" elementName="m4-2-3-2-repeat-dose-toxicity">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.3" name="Genotoxicity" content="NV" header="yes" elementName="m4-2-3-3-genotoxicity"/>
	<section number="4.2.3.3.1" name="In Vitro" content="NV" elementName="m4-2-3-3-1-in-vitro">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.3.2" name="In Vivo" content="NV" elementName="m4-2-3-3-2-in-vivo">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.4" name="Carcinogenicity" content="NV" header="yes" elementName="m4-2-3-4-carcinogenicity"/>
	<section number="4.2.3.4.1" name="Long-term Studies" content="NV" elementName="m4-2-3-4-1-long-term-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.4.2" name="Short- or Medium-term Studies" content="NV" elementName="m4-2-3-4-2-short-or-medium-term-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.4.3" name="Other Studies" content="NV" elementName="m4-2-3-4-3-other-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.5" name="Reproductive and Developmental Toxicity" content="NV" header="yes" elementName="m4-2-3-5-reproductive-and-developmental-toxicity"/>
	<section number="4.2.3.5.1" name="Fertility and Early Embryonic Development" content="NV" elementName="m4-2-3-5-1-fertility-and-early-embryonic-development">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.5.2" name="Embryo-fetal Development" content="NV" elementName="m4-2-3-5-2-embryo-fetal-development">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.5.3" name="Prenatal and Postnatal Development, including Maternal Function" content="NV" elementName="m4-2-3-5-3-prenatal-and-postnatal-development-including-maternal-function">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.5.4" name="Studies in which the Offspring are Dosed and/or Further Evaluated" content="NV" elementName="m4-2-3-5-4-studies-in-which-the-offspring-juvenile-animals-are-dosed-and-or-further-evaluated">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.6" name="Local Tolerance" content="NV" elementName="m4-2-3-6-local-tolerance">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7" name="Other Toxicity Studies" content="NV" header="yes" elementName="m4-2-3-7-other-toxicity-studies"/>
	<section number="4.2.3.7.1" name="Antigenicity" content="NV" elementName="m4-2-3-7-1-antigenicity">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7.2" name="Immunotoxicity" content="NV" elementName="m4-2-3-7-2-immunotoxicity">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7.3" name="Mechanistic Studies" content="NV" elementName="m4-2-3-7-3-mechanistic-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7.4" name="Dependence" content="NV" elementName="m4-2-3-7-4-dependence">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7.5" name="Metabolites" content="NV" elementName="m4-2-3-7-5-metabolites">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7.6" name="Impurities" content="NV" elementName="m4-2-3-7-6-impurities">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.2.3.7.7" name="Other" content="NV" elementName="m4-2-3-7-7-other">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="4.3" name="Literature References" content="NV" header="yes" elementName="m4-3-literature-references"/>
	<section number="4.3" name="[AUTHOR DATE]" content="NV" elementName="m4-3-literature-references">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5" name="Clinical Study Reports" content="NV" header="yes" elementName="m5-clinical-study-reports"/>
	<section number="5.2" name="Tabular Listing of All Clinical Studies" content="NV" elementName="m5-2-tabular-listing-of-all-clinical-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3" name="Clinical Study Reports" content="NV" header="yes" elementName="m5-3-clinical-study-reports"/>
	<section number="5.3.1" name="Reports of Biopharmaceutic Studies" content="NV" header="yes" elementName="m5-3-1-reports-of-biopharmaceutic-studies"/>
	<section number="5.3.1.1" name="Bioavailability (BA) Study Reports" content="NV" elementName="m5-3-1-1-bioavailability-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.1.2" name="Comparative BA and Bioequivalence (BE) Study Reports" content="NV" elementName="m5-3-1-2-comparative-ba-and-bioequivalence-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.1.3" name="In Vitro - In Vivo Correlation Study Reports" content="NV" elementName="m5-3-1-3-in-vitro-in-vivo-correlation-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.1.4" name="Reports of Bioanalytical and Analytical Methods for Human Studies" content="NV" elementName="m5-3-1-4-reports-of-bioanalytical-and-analytical-methods-for-human-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.2" name="Reports of Studies Pertinent to Pharmacokinetics using Human Biomaterials" content="NV" header="yes" elementName="m5-3-2-reports-of-studies-pertinent-to-pharmacokinetics-using-human-biomaterials"/>
	<section number="5.3.2.1" name="Plasma Protein Binding Study Reports" content="NV" elementName="m5-3-2-1-plasma-protein-binding-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.2.2" name="Reports of Hepatic metabolism and Drug Interaction Studies" content="NV" elementName="m5-3-2-2-reports-of-hepatic-metabolism-and-drug-interaction-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.2.3" name="Reports of Studies Using Other Human Biomaterials" content="NV" elementName="m5-3-2-3-reports-of-studies-using-other-human-biomaterials">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.3" name="Reports of Human Pharmacokinetic (PK) Studies" content="NV" header="yes" elementName="m5-3-3-reports-of-human-pharmacokinetics-pk-studies"/>
	<section number="5.3.3.1" name="Healthy Subject PK and Initial Tolerability Study Reports" content="NV" elementName="m5-3-3-1-healthy-subject-pk-and-initial-tolerability-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.3.2" name="Patient PK and Initial Tolerability Study Reports" content="NV" elementName="m5-3-3-2-patient-pk-and-initial-tolerability-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.3.3" name="Intrinsic Factor PK Study Reports" content="NV" elementName="m5-3-3-3-intrinsic-factor-pk-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.3.4" name="Extrinsic Factor PK Study Reports" content="NV" elementName="m5-3-3-4-extrinsic-factor-pk-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.3.5" name="Population PK Study Reports" content="NV" elementName="m5-3-3-5-population-pk-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.4" name="Reports of Human Pharmacodynamic (PD) Studies" content="NV" header="yes" elementName="m5-3-4-reports-of-human-pharmacodynamics-pd-studies"/>
	<section number="5.3.4.1" name="Healthy Subject PD and PK/PD Study Reports" content="NV" elementName="m5-3-4-1-healthy-subject-pd-and-pk-pd-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.4.2" name="Patient PD and PK/PD Study Reports" content="NV" elementName="m5-3-4-2-patient-pd-and-pk-pd-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.5" name="Reports of Efficacy and Safety Studies" content="NV" header="yes" elementName="m5-3-5-reports-of-efficacy-and-safety-studies"/>
	<section number="5.3.5.1" name="Study Reports of Controlled Clinical Studies Pertinent to the Claimed Indication" content="NV" elementName="m5-3-5-1-study-reports-of-controlled-clinical-studies-pertinent-to-the-claimed-indication">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.5.2" name="Study Reports of Uncontrolled Clinical Studies" content="NV" elementName="m5-3-5-2-study-reports-of-uncontrolled-clinical-studies">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.5.3" name="Reports of Analyses of Data from More than One Study" content="NV" elementName="m5-3-5-3-reports-of-analyses-of-data-from-more-than-one-study">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.5.4" name="Other Study Reports" content="NV" elementName="m5-3-5-4-other-study-reports">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="E"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.6" name="Reports of Postmarketing Experience" content="NV" header="yes" elementName="m5-3-6-reports-of-postmarketing-experience"/>
	<section number="5.3.6" name="[DESCRIPTION]" content="NV" elementName="node-extension-536">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.3.7" name="Case Report Forms and Individual Patient Listings" content="NV" header="yes" elementName="m5-3-7-case-report-forms-and-individual-patient-listings"/>
	<section number="5.3.7" name="[DESCRIPTION]" content="NV" elementName="node-extension-537">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
	<section number="5.4" name="Literature References" content="NV" header="yes" elementName="m5-4-literature-references"/>
	<section number="5.4" name="[AUTHOR DATE]" content="NV" elementName="m5-4-literature-references">
		<subType code="sub-type-1" displayName="New Chemical Entity" content="P"/>
		<subType code="sub-type-2" displayName="New Generic (Multi-source)" content="P"/>
		<subType code="sub-type-3" displayName="New Complementary" content=""/>
		<subType code="sub-type-4" displayName="New Biological" content="P"/>
		<subType code="sub-type-5" displayName="New Biosimilar" content="P"/>
		<subType code="sub-type-6" displayName="New Clinical Trial Application" content=""/>
		<subType code="sub-type-7" displayName="New Vaccines" content="P"/>
		<subType code="sub-type-8" displayName="New VAMF" content=""/>
		<subType code="sub-type-9" displayName="New SMF" content=""/>
		<subType code="sub-type-10" displayName="New APIMF" content=""/>
		<subType code="sub-type-11" displayName="New PMF" content=""/>
		<subType code="sub-type-12" displayName="Line extension-New Strength" content="P"/>
		<subType code="sub-type-14" displayName="Line extension - New Application (De-Linking of Application)" content="NV"/>
		<subType code="sub-type-15" displayName="Clone" content="P"/>
		<subType code="sub-type-16" displayName="Replica-Same" content="P"/>
		<subType code="sub-type-17" displayName="Type IA-Quality" content="NV"/>
		<subType code="sub-type-41" displayName="Type IA-Clinical" content="NV"/>
		<subType code="sub-type-22" displayName="Type IA-Inspectorate" content="NV"/>
		<subType code="sub-type-23" displayName="Type IAin-Inspectorate" content="NV"/>
		<subType code="sub-type-18" displayName="Type IAin-Clinical" content="NV"/>
		<subType code="sub-type-19" displayName="Type IAin-Quality" content="NV"/>
		<subType code="sub-type-20" displayName="Type IB-Clinical" content="NV"/>
		<subType code="sub-type-21" displayName="Type IB-Quality" content="NV"/>
		<subType code="sub-type-45" displayName="Type IB-Inspectorate" content="NV"/>
		<subType code="sub-type-38" displayName="Grouped Variation Clinical" content="NV"/>
		<subType code="sub-type-39" displayName="Grouped Variation Quality" content="NV"/>
		<subType code="sub-type-40" displayName="Grouped Variation Inspectorate" content="NV"/>
		<subType code="sub-type-24" displayName="Type II-Safety (Clinical)" content="NV"/>
		<subType code="sub-type-25" displayName="Type II-Safety and Efficacy (Clinical)" content="NV"/>
		<subType code="sub-type-44" displayName="Type II-Inspectorate" content="NV"/>
		<subType code="sub-type-49" displayName="Type II - Grouped Variation N &amp; S" content="NV"/>
		<subType code="sub-type-26" displayName="Type II-Quality" content="NV"/>
		<subType code="sub-type-27" displayName="Type II-Rescheduling" content="NV"/>
		<subType code="sub-type-28" displayName="Type II-Proprietary Name Change" content="NV"/>
		<subType code="sub-type-29" displayName="Type II-Change in Applicant-Relinquishing" content="NV"/>
		<subType code="sub-type-30" displayName="Type II-Change in Applicant-Acquiring" content="NV"/>
		<subType code="sub-type-31" displayName="Baseline" content="NV"/>
		<subType code="sub-type-47" displayName="z-Code - Type IAin" content="NV"/>
		<subType code="sub-type-50" displayName="z-Code - Type IA" content="NV"/>
		<subType code="sub-type-48" displayName="z-Code - Type IB" content="NV"/>
		<subType code="sub-type-32" displayName="z-Code - Type II" content="NV"/>
		<subType code="sub-type-33" displayName="Pharmacovigilance" content="NV"/>
		<subType code="sub-type-34" displayName="USRN - Clinical &amp; Pharmacovigilance" content="NV"/>
		<subType code="sub-type-35" displayName="Application Withdrawal/Cancellation" content="NV"/>
		<subType code="sub-type-36" displayName="Renewal" content="XE"/>
		<subType code="sub-type-37" displayName="Undefined Regulatory Activity" content="NV"/>
	</section>
</sub_type_vs_toc>